Articles

May 9, 2022 Building a Collaborative Framework for Facilitating Patient Access to Innovative Therapies Alnylam worked with leading European economists and other healthcare experts to develop what we call the Value-Based Negotiation Framework (VBNF) to help... Read More ›
April 15, 2022 2021 Annual Report: CEO Yvonne Greenstreet Reflects on an Important Year in the RNAi Revol ... In conjunction with the publishing of Alnylam's 2021 Annual Report, Alnylam's CEO Yvonne Greenstreet reflects on the year that was... Read More ›
April 2, 2022 The Making of Two of Me: Living with Porphyria Cynthia Lowen, Emmy-nominated filmmaker, talks about the making of Two of Me: Living with Porphyria. Read More ›
March 16, 2022 Alnylam Publishes 2021 Corporate Responsibility Report We're committed to taking bold actions that improve the health of humanity. Our 2021 Corporate Responsibility Report provides details on our progress... Read More ›
February 28, 2022 Supporting Health Equity for All Through Leadership, Action and Partnership "Health equity" means that everyone has a fair and just opportunity to live the healthiest life possible, regardless of who they are, where they live or how... Read More ›
February 4, 2022 Alnylam Receives Prestigious Massachusetts Economic Impact Award We are pleased and honored to have been named a Gold Team Massachusetts Economic Impact Award winner for 2022 by MassEcon. Read More ›
January 26, 2022 Alnylam Named to Bloomberg's Gender-Equality Index for 2nd Year in a Row Alnylam has been named to Bloomberg's 2022 Gender-Equality Index (GEI) - an important diversity, equity and inclusion benchmark, for the 2nd year in a row. Read More ›
December 21, 2021 Alnylam Publishes 2021 Patient Access Philosophy Report Alnylam has published its 2021 Patient Access Philosophy Report detailing its actions as a company to provide access to its medicines for those who may... Read More ›
December 16, 2021 Guest Post: Creating Connections to Support the hATTR Amyloidosis Community Susanne Berglund is the Chancellor of FAMY Norrbotten, an amyloidosis patient advocacy group reflects on the importance of making connections to support... Read More ›
December 2, 2021 Alnylam Named #1 Largest Employer in MA for 2021 by The Boston Globe Alnylam was named to The Boston Globe's Top Places to Work list for the 7th year in a row and the #1 company in the Largest employer category. Read More ›
Subscribe to Articles